165
Followers
1
Posts
127
KEYMED BIOSCIENCES INC
(HKEX: 2162)
Keymed Biosciences, Inc. is an investment holding company, which engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas. It operates through Hong Kong and China geographical segment. The company was founded on April 23, 2018 and is headquartered in Chengdu, China.
59.100 -
+0.150
(+0.25%)
Range
58.350 - 60.150
(3.08%)
Open
59.200
Previous Close
58.950
Bid Price
59.100
Bid Volume
('000)
12.5
Ask Price
59.150
Ask Volume
('000)
2.5
Volume
('000)
1,213.3
Value
71,775,198
Remark
-
Delayed prices. Updated at 05 Dec 2025 16:09.
Data powered by
View All Events
165
Loading Chart...
Please login to view stock data and analysis
